Syngene International (SYNGENE)₹436.90+0.51%Healthcare Research, Analytics & Technology
At the end of the Sep 2026 quarter, Syngene International's shareholders were: promoters 52.64%, FIIs 10.16%, DIIs 29.34%, public 7.45%, others 0.41%. Promoter holding is unchanged on the quarter. FII holding is down 6.18 percentage points from 16.34% a year earlier. 0.00% of promoter shares were pledged. It had 1,34,054 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 54.84% | 54.84% | 54.77% | 54.77% | 52.79% | 52.79% | 52.73% | 52.73% | 52.73% | 52.73% | 52.64% | 52.64% |
| FIIs | 21.23% | 20.95% | 20.67% | 20.75% | 20.68% | 19.50% | 16.54% | 16.34% | 14.99% | 13.94% | 11.85% | 10.16% |
| DIIs | 14.66% | 15.83% | 16.81% | 17.52% | 19.55% | 21.53% | 24.08% | 24.65% | 25.86% | 26.47% | 28.04% | 29.34% |
| Public | 8.95% | 8.07% | 7.32% | 6.62% | 6.69% | 5.89% | 6.34% | 5.98% | 6.13% | 6.57% | 7.04% | 7.45% |
| Others | 0.32% | 0.31% | 0.43% | 0.34% | 0.29% | 0.29% | 0.31% | 0.30% | 0.29% | 0.29% | 0.43% | 0.41% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,21,922 | 1,15,890 | 1,20,059 | 1,07,375 | 1,28,850 | 1,25,133 | 1,42,359 | 1,36,108 | 1,31,795 | 1,35,652 | 1,42,326 | 1,34,054 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Biocon Limited | Promoter | 52.29% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Pha | DII | 7.96% | +0.27 |
| Icici Prudential Mnc Fund | DII | 6.81% | New |
| Dsp Nifty 500 Index Fund | DII | 4.69% | New |
| Sbi Nifty Smallcap 250 Etf | DII | 3.11% | New |
| Life Insurance Corporation Of India | DII | 1.77% | 0.00 |
| Government Of Singapore | FII | 1.15% | −0.97 |
| Mirae Asset Focused Fund | DII | 1.06% | New |
| Tata India Innovation Fund | DII | 1.03% | New |
| Biocon Limited Employee Welfare Trust | Promoter | 0.26% | New |
| Kiran Mazumdar Shaw | Promoter | 0.01% | 0.00 |
| Icici Prudential Nifty Smallcap 250 Etf | DII | Exited | — |
| Dsp Nifty Smallcap 250 Index Fund | DII | Exited | — |
| Sbi Nifty Smallcap 250 Index Fund | DII | Exited | — |
| Mirae Asset Nifty 500 Healthcare Etf | DII | Exited | — |
| Hsbc Mutual Fund - Hsbc Midcap Fund | DII | Exited | — |
| BIOCON LIMITED EMPLOYEE WELFARE TRUST (MURALI KRISHNAN K N and K NANDA KUMAR) | Promoter | Exited | — |
Promoters held 52.64% of Syngene International at the end of the Sep 2026 quarter, down 0.09 percentage points from 52.73% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 10.16% (down 1.69 percentage points from 11.85% a quarter earlier) and domestic institutions (DIIs) held 29.34% (up 1.30 percentage points from 28.04% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Syngene International had 1,34,054 shareholders at the end of the Sep 2026 quarter, against 1,36,108 a year earlier.
Nippon Life India Trustee Ltd-A/C Nippon India Pha (DII) held 7.96% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.